[Angiotensin II analogue and essential hypertension]. 1979

T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D015059 1-Sarcosine-8-Isoleucine Angiotensin II An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR. 1-Sar-8-Ile Angiotensin II,1-(N-Methylglycine)-8-L-Isoleucine-Angiotensin II,Sarile,1 Sar 8 Ile Angiotensin II,1 Sarcosine 8 Isoleucine Angiotensin II,Angiotensin II, 1-Sar-8-Ile,Angiotensin II, 1-Sarcosine-8-Isoleucine

Related Publications

T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
August 1976, Japanese circulation journal,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
February 1977, British medical journal,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
August 1976, Australian and New Zealand journal of medicine,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
August 1976, Australian and New Zealand journal of medicine,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
March 1975, Horumon to rinsho. Clinical endocrinology,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
November 2003, Acta pharmacologica Sinica,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
July 1970, Endocrinologia e scienza della costituzione,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
April 1995, Hypertension (Dallas, Tex. : 1979),
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
December 1984, Klinische Wochenschrift,
T Kono, and F Ikeda, and F Oseko, and H Imura, and S Shimbo, and J Endo
December 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Copied contents to your clipboard!